These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

237 related articles for article (PubMed ID: 17535947)

  • 1. Quality of care in a Medicaid population with bipolar I disorder.
    Busch AB; Huskamp HA; Landrum MB
    Psychiatr Serv; 2007 Jun; 58(6):848-54. PubMed ID: 17535947
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Quality of care for Medicaid-enrolled youth with bipolar disorders.
    Fontanella CA; Hiance-Steelesmith DL; Gilchrist R; Bridge JA; Weston D; Campo JV
    Adm Policy Ment Health; 2015 Mar; 42(2):126-38. PubMed ID: 24729042
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Receipt of guideline-concordant pharmacotherapy among children with new diagnoses of bipolar disorder.
    Dusetzina SB; Gaynes BN; Weinberger M; Farley JF; Sleath B; Hansen RA
    Psychiatr Serv; 2011 Dec; 62(12):1443-9. PubMed ID: 22193791
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effects of Medicare Part D on guideline-concordant pharmacotherapy for bipolar I disorder among dual beneficiaries.
    Burns ME; Busch AB; Madden JM; Le Cates RF; Zhang F; Adams AS; Ross-Degnan D; Soumerai SB; Huskamp HA
    Psychiatr Serv; 2014 Mar; 65(3):323-9. PubMed ID: 24337444
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Enhancing multiyear guideline concordance for bipolar disorder through collaborative care.
    Bauer MS; Biswas K; Kilbourne AM
    Am J Psychiatry; 2009 Nov; 166(11):1244-50. PubMed ID: 19797436
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Psychotherapy, symptom outcomes, and role functioning over one year among patients with bipolar disorder.
    Miklowitz DJ; Otto MW; Wisniewski SR; Araga M; Frank E; Reilly-Harrington NA; Lembke A; Sachs GS
    Psychiatr Serv; 2006 Jul; 57(7):959-65. PubMed ID: 16816280
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Higher costs and therapeutic factors associated with adherence to NCQA HEDIS antidepressant medication management measures: analysis of administrative claims.
    Robinson RL; Long SR; Chang S; Able S; Baser O; Obenchain RL; Swindle RW
    J Manag Care Pharm; 2006; 12(1):43-54. PubMed ID: 16420107
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Bipolar-I depression outpatient treatment quality and costs in usual care practice.
    Busch AB; Frank RG; Sachs G
    Psychopharmacol Bull; 2008; 41(2):24-39. PubMed ID: 18668015
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The impact of unrecognized bipolar disorders among patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program: a 6-year retrospective analysis.
    McCombs JS; Ahn J; Tencer T; Shi L
    J Affect Disord; 2007 Jan; 97(1-3):171-9. PubMed ID: 16860396
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The impact of unrecognized bipolar disorders for patients treated for depression with antidepressants in the fee-for-services California Medicaid (Medi-Cal) program.
    Shi L; Thiebaud P; McCombs JS
    J Affect Disord; 2004 Nov; 82(3):373-83. PubMed ID: 15555688
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A review of bipolar disorder among adults.
    Hilty DM; Brady KT; Hales RE
    Psychiatr Serv; 1999 Feb; 50(2):201-13. PubMed ID: 10030478
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Adjunctive antidepressant use and symptomatic recovery among bipolar depressed patients with concomitant manic symptoms: findings from the STEP-BD.
    Goldberg JF; Perlis RH; Ghaemi SN; Calabrese JR; Bowden CL; Wisniewski S; Miklowitz DJ; Sachs GS; Thase ME
    Am J Psychiatry; 2007 Sep; 164(9):1348-55. PubMed ID: 17728419
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Treatment costs related to bipolar disorder and comorbid conditions among Medicaid patients with bipolar disorder.
    Guo JJ; Keck PE; Li H; Patel NC
    Psychiatr Serv; 2007 Aug; 58(8):1073-8. PubMed ID: 17664518
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Methodological approach to inter "guideline" variability in the management of bipolar disorders].
    Samalin L; Llorca PM
    Encephale; 2012 Apr; 38(2):126-32. PubMed ID: 22516270
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Gender differences in outcome at 2-year follow-up of treated bipolar and depressed alcoholics.
    Farren CK; Snee L; McElroy S
    J Stud Alcohol Drugs; 2011 Sep; 72(5):872-80. PubMed ID: 21906514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Psychosocial treatments for bipolar depression: a 1-year randomized trial from the Systematic Treatment Enhancement Program.
    Miklowitz DJ; Otto MW; Frank E; Reilly-Harrington NA; Wisniewski SR; Kogan JN; Nierenberg AA; Calabrese JR; Marangell LB; Gyulai L; Araga M; Gonzalez JM; Shirley ER; Thase ME; Sachs GS
    Arch Gen Psychiatry; 2007 Apr; 64(4):419-26. PubMed ID: 17404119
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Psychotherapy and pharmacotherapy in depression.
    Powers RH; Kniesner TJ; Croghan TW
    J Ment Health Policy Econ; 2002 Dec; 5(4):153-61. PubMed ID: 14578549
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Developing an individualized treatment plan for patients with schizoaffective disorder: from pharmacotherapy to psychoeducation.
    Vieta E
    J Clin Psychiatry; 2010; 71 Suppl 2():14-9. PubMed ID: 21190648
    [TBL] [Abstract][Full Text] [Related]  

  • 19. ECNP consensus meeting. Bipolar depression. Nice, March 2007.
    Goodwin GM; Anderson I; Arango C; Bowden CL; Henry C; Mitchell PB; Nolen WA; Vieta E; Wittchen HU
    Eur Neuropsychopharmacol; 2008 Jul; 18(7):535-49. PubMed ID: 18501566
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Pharmacologic response to a diagnosis of late-life depression: A population study in Quebec.
    Sewitch MJ; Blais R; Rahme E; Galarneau S; Bexton B
    Can J Psychiatry; 2006 May; 51(6):363-70. PubMed ID: 16786817
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.